Find premium company profiles - docstoc

DocStore » Research Reports » Company Profiles

Per Page: 15 25 50

3...

Catalyst Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Catalyst Biosciences, Inc. (Catalyst) is a biopharmaceutical company, based in the US. The company discovers and develops therapeutic protease products. It has developed Alterase Therapeutics that cleaves disease-causing proteins or improve the biochemical and pharmacological properties of marketed protease drugs. Catalyst signed a worldwide exclusive licensing agreement with Wyeth Pharmaceuticals for discovery and research of novel FVIIa variants, including improved FVIIa proteases. The company is partnered with MedImmun to discover and develop Alterase Therapeutics targeting inflammatory and autoimmune diseases. It has also developed a discovery engine that includes protein engineering, protein production, multiple assays and in vivo models. Catalyst is headquartered in South San Francisco, California, the US.
Sanitas AB (SAN1L) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Sanitas AB (Sanitas) is a publicly held pharmaceutical company. The company is involved in the manufacture, development, and sale of generic medicines. Its principal activities include the development of new products and contract manufacturing of pharmaceuticals. The company offers products in various forms, including tablets, capsules, eye drops, ointments, injectables, sterile powders, and semi solids. Sanitas also provides contract manufacturing services, as well as involves in real estate activities. The company operates its business through has four reportable operating segments, namely, Injectables, Tablets, Ointments, and Eye Drops and Pre-filled Syringes. It primarily sells its products in Poland, the Russian Federation, Latvia, Germany, Slovakia, and Lithuania. Sanitas AB is headquartered in Kaunas, Lithuania.
Qinghai Gelatin Company Limited (000606) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Qinghai Gelatin Company Limited (QGCL) is a pharmaceutical company, based in China. The company manufactures and markets gelatin and hard capsules for medicine, industrial, and photography industries. Its products include gelatin series, hard gelatin capsule series, soft capsule series and series if refined bone particles. The company’s gelatin series include photographic gelatin, edible gelatin, DCP and pharmaceutical gelatin. Its soft capsule series include the wolfberry oil soft capsule, rich in selenium ginkgo leaves soft capsules, cordyceps yak whip soft capsules, lycopene soft capsule, high calcium spirulina soft capsule, walnut oil soft capsule, carotene Soft capsule, ching mai duowei nutrition soft capsules, MI treasure shark wellcome soft capsule, the linglong calcium (student type) soft capsules and placenta soft capsule. The company provides ancillary materials for pharmaceuticals, pharmaceutical packaging services, the leasing of plants and investment business. Its products are marketed throughout China. QGCL is headquartered in Xining, China.
TMC Life Sciences Berhad (TMCLIFE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

TMC Life Sciences Berhad (TMC Life) is a healthcare service provider, based in Malaysia. It provides investment and funding services for the medical and healthcare industry. The company has four subsidiaries. TMC Fertility Centre provides provision of fertility services; Tropicana Medical Centre (M) Sdn Bhd serves in the operation of a medical centre, which provides various services related to women; Stemtech International Sdn Bhd provides services such as storage of cord blood and adult stem cells, research and development and application of stem cell therapy; and Tropicana Wellness providing development, marketing and management of health care programs. TMC Life is headquartered in Selangor, Malaysia.
C&O Pharmaceutical Technology (Holdings) Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

C&O Pharmaceutical Technology (C&O Pharmaceutical) is a health care pharmaceutical company, based in Hong Kong. The company conducts research, produces and distributes pharmaceutical products. Its products include tablets, capsules, granules, and creams for use in bottled injections, active pharmaceutical ingredients with anti-infection and gastrointestinal drugs, drugs for aging adults and other specialized drugs. C&O Pharmaceutical conducts research in the area of chemical synthesis, drug formulation and preparation methods to clinical research, product registration, manufacturing techniques and pharmaceutical analysis. The company has an alliance with Optimer Pharmaceuticals, Inc for co-operation in the research and development. It is a subsidiary of Shionogi & Co., Ltd. C&O Pharmaceutical is headquartered in Kowloon, Hong Kong.
Ruyan Group (Holdings) Limited (329) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Ruyan Group (Holdings) Limited (Ruyan) is an investment holding company, based in Hong Kong. The company manufactures and sells health care products, pharmaceutical products, and Ruyan atomizing cigarettes. It conducts research and develops healthcare and pharmaceutical products. Ruyan has presence in China, Hong Kong, the US and British Virgin Islands. The company markets its products through brand Ruyan. It operates through its wholly owned subsidiary, Chenlong Group Limited. The company was formerly known as, Ruyan Group (Holdings) Limited. It is publicly listed in Hong Kong Stock Exchange. Ruyan is headquartered in Hong Kong, Hong Kong Special Administrative Region of China.
Swissmed Centrum Zdrowia S.A. (SWD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Swissmed Centrum Zdrowia SA (Swissmed) is a medical organization, based in Poland. The organization constructs and operates health care facilities to serve patients. It operates a multi-specialty hospital with 73-bed facility that provides general surgery, hand surgery, foot surgery, vascular surgery, gynecology, plastic surgery, orthopaedics, oncological surgery, laryngology, pediatric surgery, and neurosurgery services. Swissmed also operates six outpatient clinics that offer diagnostic tests such as endoscopy, ultrasound scans, X-ray tests, computer tomography, perimetric tests, and non-contact examination of intraocular pressure. It provides medical services to individual patients, business and government organisations, insurance companies and foreign visitors to Poland. The organization was incorporated in the year 1996. Swissmed is headquartered in Gdansk, Poland.
SemBiosys Genetics Inc. (SBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

SemBiosys Genetics Inc. (SemBioSys) is an agricultural biotechnology company, based in Canada. The company utilizes plant seed based oilbody and genetic expression technology platforms to develop proteins and oils, and drug candidates in oil seed producing plant species. It produces nutritional and industrial oils, enzymes, functional food ingredients, and agricultural products. SemBioSys through its technology called Stratosome Biologic System, which provides solution for drugs needed for the number of people affected by disease and high dosage requirements. The company‘s current pharmaceutical product candidates include insulin for diabetes and Apo AIMilano for cardiovascular disease. Its personal care products are marketed by its spin-out company, Botaneco. SemBioSys is headquartered in Alberta, Calgary, Canada.
Sirion Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Sirion Therapeutics, Inc. (Sirion) is a private pharmaceutical company, is involved in the discovery, development and commercialization of products for the treatment of various ophthalmic diseases and for protection and preservation of eyesight. Its product portfolio includes durezol for the treatment of inflammation and pain associated with ocular surgery and zirgan for the treatment of acute herpetic keratitis (dendritic ulcers). Its developmental pipeline includes cyclosporine, an ophthalmic solution 0.1% intended for the treatment of ocular surface diseases, including dry eye syndrome, Fenretinide an oral vitamin-A binding protein antagonist targeted at geographic atrophy (GA) or dry age-related macular degeneration (AMD), ST-802, Norketotifen, SIR-1047 and SIR-1076. The aim of the company is to conduct business in ethical, fair, lawful manner and to teat patients it providing the health professionals ad government officials. Sirion Therapeutics, Inc. is headquartered in Tampa, the US.
Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Threshold Pharmaceuticals, Inc.(Threshold) is a biotechnology company involved in the discovery and development of therapeutics for the treatment of cancer. The company focuses on the hypoxic microenvironment of tumor cells and less toxic to healthy tissues than conventional treatments. Its product pipeline includes TH-302, a hypoxia-activated prodrug (HAP) for the potential treatment of solid tumors, currently undergoing late stage of clinical development; TH-302 also for the treatment of pancreatic cancer and hematologic malignancies; Glufosfamide in combination with gemcitabine for the treatment of advanced pancreatic cancer and 2-Deoxyglucose, or 2DG, for the treatment of solid tumors. In February 2012, Threshold inked an global agreement with Merck KgaA to co-develop and commercialize its phase III Hypoxia-Targeted Drug TH-302 targeting patients with soft tissue sarcoma. Threshold is headquartered in California, the US.
Resverlogix Corp. (RVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Resverlogix Corp. (Resverlogix) is a biotechnology company, based in Canada. The company develops small molecular therapeutics. Its development programs include NexVas Plaque Regression, a technology platform, which is in two Phase 2b clinical trials with RVX-208 for the development of drugs that increase ApoA-I to reduce the risk of CVD; and IL-6 and IL-17, which are cytokine mediators for the treatment of autoimmune diseases. The company’s development programs also include NexVas Alzheimer's disease that focuses on the effects of ApoA-I production on cognition, memory, and both plasma and cerebrospinal fluid biomarkers. Its ReVas program is used for the research and development of therapeutic agents to be used with medical devices and biomaterials for the local non-systemic treatment of CVD. Resverlogix is headquartered in Calgary, Alberta, Canada.
Theravance, Inc. (THRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Theravance, Inc. (Theravance) is a healthcare and pharmaceutical company, based in the US. The company discovers, develops and commercializes drugs. Its product VIBATIVE is used in the treatment of adult patients with complicated skin and skin structure infections caused by susceptible isolates. Theravance is into conducting programs on cognitive disorders, gastrointestinal motility dysfunction, CNS/Pain, bacterial infections and respiratory. The company has collaboration with GlaxoSmithKline to develop and commercialize once-daily Long-Acting Beta2 Agonist (LABA) products for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is also partnered with other pharmaceutical companies. Theravance is headquartered in South San Francisco, California, the US.
Sosei Group Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Sosei Group Corporation (Sosei) is a biopharmaceutical company, based in Japan. It develops and commercializes innovative drugs. The company’s products include NorLevo 0.75mg, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive, which is taken within 72 hours after unprotected sexual intercourse or contraceptive failure to prevent unwanted pregnancy. The company’s NVA237 is a long acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Its SO-1105 is an antifungal agent, administered as a muco-adhesive buccal tablet for the treatment of oropharyngeal candidiasis in immunocompromised patients. The company operates in Japan, Europe and North American pharmaceutical markets. Sosei is headquartered in Tokyo, Japan.
Tsukui Corporation (2398) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

TSUKUI CORPORATION (Tsukui) is a health care service company, based in Japan. The company provides a broad range of healthcare services. It operates through its business segments such as the home care, pay nursing home and manpower dispatching among others. The company’s services include nursing homes, sale and rental of care supplies, as well as employment agency services for pay nursing homes and medical institutions. Its home care business division provides day care services, care visits and home care supporting services, as well as the operation of group homes. Tsukui also dispatches manpower for medical institutions and pay nursing homes. The company was incorporated in 1969. Tsukui is headquartered in Yokohama, Japan.
PharmaGap Inc. (GAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

PharmaGap Inc. (PharmaGap) is a biotechnology company, based in Canada. The company develops therapeutics for several types of cancer. It develops drug candidate, GAP-107B8 that targets protein Kinase C in the pre-clinical development stage for the treatment of cancer. PharmaGap is developing GAP-107B8 through a computer assisted rational drug design based on its extensive expertise in the area of cell signaling pathways. The company also develops drug modulators targeting PKC isoforms for the treatment of conditions such as heart disease and diabetes. It has collaborated with MD biosciences for the development of an inhibitor of PKC isoform for use in inflammation and neurology diseases. Pharmagap is headquartered in Ottawa, Ontario, Canada.

Per Page: 15 25 50

3...

Company Profiles

Find premium company profile research reports. Purchase and download high quality report analysis, company reports, and much more

DocStore Search:

DocStore » Research Reports » Company Profiles

Catalyst Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sanitas AB (SAN1L) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Qinghai Gelatin Company Limited (000606) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TMC Life Sciences Berhad (TMCLIFE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

C&O Pharmaceutical Technology (Holdings) Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ruyan Group (Holdings) Limited (329) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Swissmed Centrum Zdrowia S.A. (SWD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SemBiosys Genetics Inc. (SBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sirion Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Resverlogix Corp. (RVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Theravance, Inc. (THRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sosei Group Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tsukui Corporation (2398) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PharmaGap Inc. (GAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile